Clinical Trials
21 trialsNCT05475171 2026-05-22
Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
M.D. Anderson Cancer Center
Phase 2 Suspended
NCT04840589 2026-05-13
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors
National Cancer Institute (NCI)
Phase 1 Suspended
NCT04929015 2026-05-04
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
Rutgers, The State University of New Jersey
Phase NA Suspended
NCT05337735 2026-05-04
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
M.D. Anderson Cancer Center
Phase 2 Suspended
NCT05866679 2026-04-15
Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging
M.D. Anderson Cancer Center
Phase 1 Suspended
NCT05000294 2026-02-18
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
Phase 1/2 Suspended
NCT03065062 2026-02-13
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
Dana-Farber Cancer Institute
Phase 1 Suspended
NCT03875144 2026-02-09
MESOTIP
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Suspended
NCT06666218 2026-01-14
Helping Ovarian Cancer Patients Cope With Their Illness (HOPE)
Fred Hutchinson Cancer Center
Phase NA Suspended
NCT05958199 2025-06-27
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
NextPoint Therapeutics, Inc.
Phase 1 Suspended
NCT04711161 2024-01-23
First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.
Green3Bio, Inc.
Phase 1 Suspended
NCT04042116 2022-12-20
A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor
Clovis Oncology, Inc.
Phase 1/2 Suspended
NCT03970382 2022-08-18
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
PACT Pharma, Inc.
Phase 1 Suspended
NCT03095664 2021-07-01
Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors
Brazilian National Cancer Institute
Phase NA Suspended
NCT01218490 2019-05-16
CARACO
Institut Cancerologie de l'Ouest
Phase 3 Suspended
NCT02093871 2017-07-21
PISH-2
ThermalCore Inc
Phase 1 Suspended
NCT02742428 2017-05-02
Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer
Gdynia Oncology Center
Phase NA Suspended
NCT01342653 2016-11-21
HIPEC
Hospital General Universitario Gregorio Marañon
Phase 2 Suspended
NCT00865488 2009-12-23
Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery
OMRIX Biopharmaceuticals
Phase 3 Suspended
NCT00921635 2009-06-19
HOSTT
Tri-Service General Hospital
Phase 3 Suspended
NCT00753480 2008-11-07
A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Genentech, Inc.
Phase 1 Suspended